CERVA, CARLOTTA
 Distribuzione geografica
Continente #
NA - Nord America 416
AS - Asia 161
EU - Europa 122
SA - Sud America 30
AF - Africa 2
Totale 731
Nazione #
US - Stati Uniti d'America 410
SG - Singapore 91
IT - Italia 36
BR - Brasile 29
CN - Cina 27
DE - Germania 18
IE - Irlanda 17
HK - Hong Kong 12
FI - Finlandia 9
VN - Vietnam 8
RU - Federazione Russa 7
GB - Regno Unito 6
SE - Svezia 6
CA - Canada 5
FR - Francia 5
ID - Indonesia 5
BE - Belgio 3
ES - Italia 3
IN - India 3
KR - Corea 3
AT - Austria 2
BD - Bangladesh 2
CZ - Repubblica Ceca 2
IQ - Iraq 2
JP - Giappone 2
LV - Lettonia 2
NL - Olanda 2
PL - Polonia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
CH - Svizzera 1
HU - Ungheria 1
IR - Iran 1
JO - Giordania 1
MA - Marocco 1
MX - Messico 1
TW - Taiwan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 731
Città #
Wilmington 77
Singapore 59
Houston 46
Chandler 41
Fairfield 30
Ashburn 21
Beijing 20
New York 16
Rome 16
Hong Kong 12
Dublin 11
Seattle 11
Los Angeles 10
Ann Arbor 9
Santa Clara 9
Medford 8
The Dalles 6
Woodbridge 6
São Paulo 5
Ho Chi Minh City 4
Lappeenranta 4
Lawrence 4
Modena 4
Munich 4
Nuremberg 4
Brussels 3
Cambridge 3
Chicago 3
Dallas 3
Hanoi 3
Helsinki 3
Palo Alto 3
Seoul 3
Toronto 3
Baghdad 2
Bari 2
Bengaluru 2
Buffalo 2
Council Bluffs 2
Creede 2
Düsseldorf 2
Elk Grove Village 2
Forlì 2
Guangzhou 2
Kilburn 2
London 2
Menlo Park 2
Montreal 2
Olomouc 2
Pianoro 2
Redondo Beach 2
Riga 2
San Diego 2
San Jose 2
Tashkent 2
Tokyo 2
Turku 2
Warsaw 2
Alto Paraíso de Goiás 1
Americana 1
Amman 1
Amsterdam 1
Araçariguama 1
Araçuaí 1
Barra Bonita 1
Bauru 1
Belgrade 1
Berlin 1
Boston 1
Cabrobó 1
Caracas 1
Careaçu 1
Carney 1
Casablanca 1
Chennai 1
Conceição das Alagoas 1
Depok 1
Dhaka 1
Dracena 1
Florianópolis 1
Fortaleza 1
Genoa 1
Gresik 1
Guaranésia 1
Itambaracá 1
Jaci 1
Jakarta 1
Johannesburg 1
Kecskemét 1
Kemerovo 1
Las Vegas 1
Lasswade 1
Leawood 1
Leme 1
Lorena 1
Manaus 1
Manchester 1
Mercês 1
Miami 1
Milan 1
Totale 554
Nome #
A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro 236
Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection 138
Cryptic HBV replicative activity is frequently revealed in anti-HBC-positive/hbsag-negative patients with HIV infection by highly sensitive molecular assays, and can be predicted by integrating classical and novel serological HBV markers 134
HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV Reactivation 104
Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study) 73
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 60
La riattivazione del virus dell'epatite B nel paziente ematologico: pratica clinica e prospettive future 30
Totale 775
Categoria #
all - tutte 4.535
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.535


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202196 0 0 0 0 0 18 48 14 6 0 6 4
2021/202278 2 1 0 6 1 14 6 6 25 3 0 14
2022/202385 8 9 11 8 7 18 10 6 5 0 3 0
2023/202455 4 1 3 9 11 11 5 0 4 2 0 5
2024/2025208 8 45 22 10 4 10 35 11 20 16 16 11
2025/2026160 28 15 35 40 38 4 0 0 0 0 0 0
Totale 775